[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100660162":3},{"organization":4,"outcomesModule":7,"designInfo":85,"detailedDescription":92,"studyPopulation":34,"armGroups":93,"interventions":106,"overallOfficials":34,"centralContacts":115,"locations":121,"responsibleParty":138,"collaborators":142,"id":145,"slug":146,"hasResults":147,"nctId":148,"briefTitle":149,"officialTitle":150,"acronym":34,"eligibilityCriteria":151,"healthyVolunteers":147,"sex":152,"minAge":153,"maxAge":154,"enrollmentInfo":155,"targetDuration":34,"studyType":158,"phases":159,"briefSummary":161,"conditions":162,"keywords":166,"overallStatus":171,"whyStopped":34,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":176,"completionDateStruct":178,"leadSponsor":180,"locationsCount":181},{"fullName":5,"class":6},"Gazi University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":34},[9,13,16],{"measure":10,"description":11,"timeFrame":12},"Change in body weight","Change in body weight from baseline to week 12, measured in kilograms (kg). Body weight will be measured at baseline and at weeks 4, 8, and 12 during the intervention.","Baseline to Week 12",{"measure":14,"description":15,"timeFrame":12},"Change in menopausal symptoms","Change in menopausal symptom severity assessed using the Menopause Rating Scale (MRS). The total score ranges from 0 to 44, with higher scores indicating greater symptom severity.",{"measure":17,"description":18,"timeFrame":12},"Change in sleep quality","Change in sleep quality assessed using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21, with higher scores indicating poorer sleep quality.",[20,23,26,29,32,35,37,39,41,43,45,47,49,51,53,55,57,59,61,63,65,67,69,71,73,75,77,79,81,83],{"measure":21,"description":22,"timeFrame":12},"Change in fat mass","Change in fat mass measured by bioelectrical impedance analysis using the Tanita DC 360, expressed in kilograms, and %.",{"measure":24,"description":25,"timeFrame":12},"Change in fat-free mass","Change in fat-free mass measured by bioelectrical impedance analysis using the Tanita DC 360, expressed in kilograms, and %.",{"measure":27,"description":28,"timeFrame":12},"Change in body water","Change in body water measured by bioelectrical impedance analysis using the Tanita DC 360, expressed in kilograms, and %.",{"measure":30,"description":31,"timeFrame":12},"Change in visceral fat level","Change in body water measured by bioelectrical impedance analysis using the Tanita DC 360",{"measure":33,"description":34,"timeFrame":12},"Change in body mass index (BMI)",null,{"measure":36,"description":34,"timeFrame":12},"Change in waist circumference",{"measure":38,"description":34,"timeFrame":12},"Change in hip circumference",{"measure":40,"description":34,"timeFrame":12},"Change in waist-to-height ratio",{"measure":42,"description":34,"timeFrame":12},"Change in waist-to-hip ratio",{"measure":44,"description":34,"timeFrame":12},"Change in systolic blood pressure",{"measure":46,"description":34,"timeFrame":12},"Change in diastolic blood pressure",{"measure":48,"description":34,"timeFrame":12},"Change in handgrip strength",{"measure":50,"description":34,"timeFrame":12},"Change in fasting blood glucose",{"measure":52,"description":34,"timeFrame":12},"Change in fasting insulin",{"measure":54,"description":34,"timeFrame":12},"Change in HbA1c",{"measure":56,"description":34,"timeFrame":12},"Change in total cholesterol",{"measure":58,"description":34,"timeFrame":12},"Change in HDL cholesterol",{"measure":60,"description":34,"timeFrame":12},"Change in LDL cholesterol",{"measure":62,"description":34,"timeFrame":12},"Change in triglycerides",{"measure":64,"description":34,"timeFrame":12},"Change in ALT",{"measure":66,"description":34,"timeFrame":12},"Change in AST",{"measure":68,"description":34,"timeFrame":12},"Change in ferritin",{"measure":70,"description":34,"timeFrame":12},"Change in 25-hydroxyvitamin D",{"measure":72,"description":34,"timeFrame":12},"Change in vitamin B12",{"measure":74,"description":34,"timeFrame":12},"Change in C-reactive protein",{"measure":76,"description":34,"timeFrame":12},"Change in neutrophil-to-lymphocyte ratio",{"measure":78,"description":34,"timeFrame":12},"Change in thyroid-stimulating hormone",{"measure":80,"description":34,"timeFrame":12},"Change in Framingham Risk Score",{"measure":82,"description":34,"timeFrame":12},"Change in Lipid Accumulation Product",{"measure":84,"description":34,"timeFrame":12},"Change in visceral adiposity index",{"allocation":86,"interventionModel":87,"interventionModelDescription":88,"primaryPurpose":89,"observationalModel":34,"timePerspective":34,"maskingInfo":90},"RANDOMIZED","PARALLEL","A quasi-randomized controlled, open label, parallel group study","TREATMENT",{"masking":91,"maskingDescription":34,"whoMasked":34},"NONE","Study Setting, Timing, and Sample\n\nThis study is a quasi-randomized, controlled, open-label, parallel-group intervention study. The coordinating center is the Department of Internal Medicine, Faculty of Medicine, Gazi University, and the study will be conducted among postmenopausal women attending the Internal Medicine Outpatient Clinic of Cihanbeyli State Hospital in Konya, Türkiye, who meet the eligibility criteria and agree to participate in the study.\n\nThe study will compare the effects of time-restricted eating and a personalized energy-restricted diet on anthropometric measurements, body composition, handgrip strength, blood pressure, biochemical parameters, sleep quality, and menopausal symptoms.\n\nThe sample size was determined based on changes in body weight reported in studies evaluating a personalized energy-restricted diet (Englert et al. 2023) and time-restricted eating (Grant et al. 2024) in postmenopausal women. Based on these values, the calculated effect size was Cohen's d = 1.13. A power analysis was performed using G\\*Power 3.1.9.7 based on a two-tailed independent-samples t-test. With an alpha level of 0.05, statistical power of 0.85, and an effect size of 1.13, a minimum of 16 participants per group, corresponding to 32 participants in total, was required to achieve adequate statistical power (actual power = 0.85). Considering an anticipated 20% participant loss, a total of 40 participants, with 20 participants in each group, will be recruited.\n\nParticipant recruitment is planned between November 1, 2026 and August 1, 2027.\n\nEligible individuals will be informed in detail about the study, and written informed consent will be obtained from those who agree to participate.\n\nStudy Design and Group Allocation\n\nThe study is designed as a quasi-randomized, controlled, open-label, parallel-group intervention study. Participants will be stratified according to age (\\\u003C55 and ≥55 years) and body mass index (BMI; \\\u003C35 and ≥35 kg\u002Fm²), and stratified blocks will be created. Within these strata, a web-based randomization program (Random.org) will be used to determine the initial allocation of participants to the intervention or control group.\n\nThe stratified blocks will be created to minimize potential differences in age and BMI between the intervention and control groups.\n\nAfter the allocation is communicated, participants who do not wish to follow the assigned dietary intervention may request participation in the other dietary group. Such requests may be accommodated depending on the number of participants in each group. If the requested change cannot be accommodated because of group size limitations, the participant will be withdrawn from the study.\n\nBecause of the nature of the dietary interventions, neither the participants nor the researchers can be blinded to group assignment.\n\nGeneral Study Plan\n\nThe study consists of an initial assessment and a 12-week intervention period.\n\nInitial Assessment and Pre-Visit Conditions\n\nBefore the intervention, participants will undergo a comprehensive baseline assessment. Height, body weight, waist circumference, and hip circumference will be measured, and BMI and waist-to-height ratio will be calculated.\n\nBody composition, including fat-free mass, fat mass, muscle mass, and body water, will be assessed using a Tanita DC 360 bioelectrical impedance analysis device.\n\nNutritional status will be assessed using a 3-day dietary record, including two weekdays and one weekend day. Physical activity level will be assessed using two 24-hour physical activity records, including one weekday and one weekend day.\n\nHandgrip strength will be measured using an electronic hand dynamometer. Blood pressure will be measured, and fasting venous blood samples will be collected for biochemical analyses. Menopausal symptoms will be assessed using the Menopause Rating Scale, and sleep quality will be assessed using the Pittsburgh Sleep Quality Index.\n\nParticipants will be instructed regarding the conditions required before measurements. For biochemical analyses, blood samples will be collected in the morning after at least 10 hours of fasting. Participants who do not meet the required fasting conditions will be asked to attend the study site in the morning after completing the required fasting period without consuming food or beverages.\n\nIntervention Group: Time-Restricted Eating\n\nParticipants assigned to the intervention group will receive general healthy eating recommendations for the postmenopausal period and will be instructed to follow a time-restricted eating schedule for 12 weeks. Participants will consume food within an 8-hour daily eating window and fast for 16 hours.\n\nThe starting time of the eating window will be selected by the participant between 08:00 and 12:00. During the 16-hour fasting period, water, unsweetened tea, plain coffee, and plain mineral water will be permitted.\n\nNo additional energy restriction will be prescribed in the time-restricted eating group.\n\nControl Group: Personalized Energy-Restricted Diet\n\nParticipants assigned to the control group will receive general healthy eating recommendations for the postmenopausal period and will follow a personalized energy-restricted diet for 12 weeks. The diet will be planned in accordance with the dietary recommendations provided in the guidelines of national and international menopause societies, while also considering individual dietary preferences.\n\nEnergy requirements will be estimated using the Mifflin-St Jeor equation, and the prescribed diet will provide approximately 25% less energy than the estimated daily energy requirement.\n\nParticipants will be advised to consume three main meals, consisting of breakfast between 08:00 and 10:00, lunch between 12:00 and 13:00, and dinner between 18:00 and 19:00, with one to three snacks according to individual needs.\n\nFollow-up and Monitoring\n\nDietary adherence and dietary intake will be monitored every 2 weeks using dietary records. Participants will be invited to the Dietitian Clinic of Cihanbeyli State Hospital for follow-up.\n\nAnthropometric measurements, blood pressure, and handgrip strength will be assessed every 4 weeks during the intervention. Thus, these measurements will be performed at baseline and at weeks 4, 8, and 12.\n\nAt the end of the 12-week intervention, baseline assessments will be repeated. Menopausal symptoms and sleep quality will be reassessed during the study, whereas diet satisfaction will be assessed once at the end of the study. A 3-day dietary record and two 24-hour physical activity records will be obtained, and anthropometric measurements, body composition, handgrip strength, blood pressure, and biochemical parameters will be reassessed.\n\nAnthropometric Measurements\n\nAnthropometric measurements will be performed by the study dietitian.\n\nBody weight: Body weight will be measured barefoot and wearing light clothing using a Tanita DC 360 body composition analyzer.\n\nHeight: Height will be measured using a F. BOSCH wall-mounted stadiometer, with the participant standing with the feet together and the head positioned in the Frankfurt horizontal plane.\n\nBody mass index: BMI will be calculated as body weight in kilograms divided by height in meters squared and will be evaluated according to WHO criteria (WHO, 2000).\n\nWaist circumference: Waist circumference will be measured in centimeters at the midpoint between the lowest rib and the iliac crest using a non-stretchable, flexible fiberglass measuring tape.\n\nHip circumference: Hip circumference will be measured at the widest point of the hips using a non-stretchable, flexible fiberglass measuring tape.\n\nWaist-to-height ratio: Waist-to-height ratio will be calculated by dividing waist circumference by height and will be evaluated according to the Ashwell classification (Ashwell and Hsieh, 2005).\n\nWaist-to-hip ratio: Waist-to-hip ratio will be calculated by dividing waist circumference by hip circumference.\n\nAssessment of Body Composition\n\nBody composition will be assessed by the study dietitian using a Tanita DC 360 bioelectrical impedance analysis device. Fat-free mass, fat mass, muscle mass, body water, and visceral fat level will be obtained.\n\nMeasurements will be performed in the morning under standardized conditions. Participants will be instructed to avoid strenuous physical activity for 48 hours before the measurement, refrain from eating for at least 4 hours before the test, avoid excessive fluid intake before the measurement, avoid tea and coffee for 4 hours before the measurement, and remove metal objects that may come into contact with the body during the assessment (22).\n\nHandgrip Strength\n\nHandgrip strength will be measured by the study dietitian using an electronic hand dynamometer (DEMPOWER DP434). One measurement will be obtained from each hand, and the mean of the two measurements will be used for analysis. Handgrip strength below 16 kg will be classified as low muscle strength (Cruz-Jentoft et al., 2019).\n\nAssessment of Dietary Intake\n\nNutritional intake will initially be assessed using a 3-day dietary record consisting of two weekdays and one weekend day. Reported food and beverage quantities will be converted into standard amounts by the researcher. Energy, macronutrient, and micronutrient intakes will be analyzed using the Computer-Assisted Nutrition Program, Nutrition Information Systems Package Program (BEBIS).\n\nDietary intake will be monitored every 2 weeks during the intervention to assess dietary adherence.\n\nAssessment of Physical Activity\n\nPhysical activity will be assessed using two 24-hour physical activity records, consisting of one weekday and one weekend day. The duration of sleep, lying, sedentary activities, and light, moderate, and vigorous activities during a 24-hour period will be recorded.\n\nTotal energy expenditure will be calculated by multiplying the duration of each activity by the corresponding physical activity ratio (PAR). Physical activity level (PAL) will be calculated by dividing total energy expenditure by 24 hours.\n\nAssessment of Menopausal Symptoms\n\nMenopausal symptoms will be assessed using the Turkish version of the Menopause Rating Scale, for which validity and reliability have been established (Gürkan 2005). The scale consists of 11 items and the total score ranges from 0 to 44. Higher scores indicate greater severity of menopausal symptoms.\n\nAssessment of Sleep Quality\n\nSleep quality will be assessed using the Turkish version of the Pittsburgh Sleep Quality Index, for which validity and reliability have been established (Buysse et al., 1989; Ağargün et al., 1996). The total score ranges from 0 to 21, with a score ≤5 indicating good sleep quality.\n\nAssessment of Diet Satisfaction\n\nDiet satisfaction will be assessed at the end of the intervention using the Diet Satisfaction Scale. The Turkish version of the scale has established validity and reliability. The scale consists of 9 items and uses Likert-type scoring. The maximum possible score is 45, with higher scores indicating greater diet satisfaction (Eskici \\& Karahan Yılmaz, 2021).\n\nBlood Pressure Measurement\n\nBlood pressure will be measured by the study nurse. Systolic and diastolic blood pressure (mmHg) and heart rate (beats\u002Fminute) will be measured using an automatic oscillometric blood pressure monitor (OMRON M2 Basic), with the participant seated and the measurement taken once from the right arm (Asmar et al., 2010).\n\nBefore measurement, participants will be asked about recent exercise, food intake, medication use, and tea or coffee consumption. Participants will rest for at least 5 minutes before blood pressure measurement.\n\nBiochemical Assessments\n\nVenous blood samples will be collected from all participants at baseline (week 0) and at the end of the intervention (week 12), following at least 10 hours of fasting. Blood samples will be collected by the study nurse in the morning, and all biochemical analyses will be performed in the laboratory of Cihanbeyli State Hospital.\n\nThe following parameters will be analyzed: fasting blood glucose (mg\u002FdL), fasting insulin (mIU\u002FL), HbA1c (%), total cholesterol (mg\u002FdL), HDL cholesterol (mg\u002FdL), LDL cholesterol (mg\u002FdL), triglycerides (mg\u002FdL), alanine aminotransferase (ALT; U\u002FL), aspartate aminotransferase (AST; U\u002FL), ferritin (ng\u002FmL), 25-hydroxyvitamin D (ng\u002FmL), vitamin B12 (ng\u002FL), C-reactive protein (CRP; mg\u002FL), neutrophil-to-lymphocyte ratio, and thyroid-stimulating hormone (TSH; mIU\u002FL).",[94,100],{"label":95,"type":96,"description":97,"interventionNames":98},"Time-Restricted Eating Group","EXPERIMENTAL","Participants will follow a time-restricted eating schedule for 12 weeks, consuming food within an 8-hour daily eating window and fasting for 16 hours. The starting time of the eating window will be selected by the participant between 08:00 and 12:00. During the fasting period, water, unsweetened tea, plain coffee, and plain mineral water will be permitted. No additional energy restriction will be prescribed.",[99],"Behavioral: Time-Restricted Eating",{"label":101,"type":102,"description":103,"interventionNames":104},"Personalized Energy-Restricted Diet Group","ACTIVE_COMPARATOR","Participants will follow a personalized energy-restricted diet for 12 weeks, providing approximately 25% less energy than their estimated daily energy requirement. The diet will be planned according to dietary recommendations provided in the guidelines of national and international menopause societies and individual dietary preferences.",[105],"Behavioral: Personalized Energy-Restricted Diet",[107,112],{"type":108,"name":109,"description":110,"armGroupLabels":111,"otherNames":34},"BEHAVIORAL","Time-Restricted Eating","Participants will consume food within an 8-hour daily eating window and fast for 16 hours for 12 weeks. The starting time of the eating window will be selected by the participant between 08:00 and 12:00. During the fasting period, water, unsweetened tea, plain coffee, and plain mineral water will be permitted. No additional energy restriction will be prescribed.",[95],{"type":108,"name":113,"description":103,"armGroupLabels":114,"otherNames":34},"Personalized Energy-Restricted Diet",[101],[116],{"name":117,"role":118,"phone":119,"phoneExt":34,"email":120},"Aziz Kılınç, MSc","CONTACT","+90 541-766-1850","aziz.kilinc@gazi.edu.tr",[122],{"facility":123,"status":34,"city":124,"state":125,"zip":126,"country":127,"countryCode":34,"cosmosGeoPoint":128,"geoPoint":133,"contacts":134},"Cihanbeyli State Hospital","Konya","Cihanbeyli","42850","Turkey (Türkiye)",{"type":129,"coordinates":130},"Point",[131,132],32.48464,37.87135,{"lat":132,"lon":131},[135,136],{"name":117,"role":118,"phone":119,"phoneExt":34,"email":34},{"name":34,"role":118,"phone":137,"phoneExt":34,"email":34},"+90541-766-1850",{"type":139,"investigatorFullName":140,"investigatorTitle":141,"investigatorAffiliation":5,"oldNameTitle":34,"oldOrganization":34},"PRINCIPAL_INVESTIGATOR","Aziz KILINC","Doctoral Student in Nutrition and Dietetics",[143],{"name":144,"class":6},"The Scientific and Technological Research Council of Turkey","100660162","time-restricted-eating-and-personalized-energy-restricted-diet-in-obese-postmenopausal-women-100660162",false,"NCT07874399","Time-Restricted Eating and Personalized Energy-Restricted Diet in Obese Postmenopausal Women","Effects of Time-Restricted Eating and Personalized Energy-Restricted Diet on Menopause Symptoms, Sleep Quality, and Nutritional Status in Obese Postmenopausal Women","Inclusion Criteria:\n\n* Aged 50-60 years\n* Body mass index (BMI) ≥30 and ≤40 kg\u002Fm²\n* No menstrual periods for at least 1 year\n* No history of hypoglycemia\n* No special diet during the previous 3 months and stable body weight (within ±3 kg)\n* Usual daily eating window of ≥10 hours\n\nExclusion Criteria:\n\n* Surgical menopause\n* Current use of hormone replacement therapy\n* Current use of lipid-lowering, glucose-lowering, antihypertensive, corticosteroid, or anticoagulant medications\n* Current use of weight-loss medications (e.g., orlistat, liraglutide) or diuretics\n* Diagnosis of cancer within the previous 5 years\n* Kidney disease, liver disease (except fatty liver disease), heart failure, type 1 or type 2 diabetes mellitus, or uncontrolled hypertension\n* Severe psychiatric disorders (e.g., anxiety disorder or schizophrenia)\n* Active metabolic bone diseases (e.g., Paget disease or osteomalacia)\n* Diagnosis of an eating disorder\n* Current treatment for a sleep disorder\n* Current smoking and\u002For alcohol use\n* Working night shifts (between 11:00 PM and 6:00 AM)\n* Conditions requiring a special diet, such as celiac disease","FEMALE","50 Years","60 Years",{"count":156,"type":157},40,"ESTIMATED","INTERVENTIONAL",[160],"NA","This clinical study aims to compare the effects of time-restricted eating and a personalized energy-restricted diet on anthropometric measurements, body composition, biochemical parameters, blood pressure, handgrip strength, menopausal symptoms, and sleep quality in obese postmenopausal women. The study is a 12-week, open-label, controlled, parallel-group clinical trial with a quasi-randomized allocation design. The coordinating center is the Department of Internal Medicine, Faculty of Medicine, Gazi University, and the study will be conducted at the Internal Medicine Outpatient Clinic of Cihanbeyli State Hospital in Konya, Türkiye.\n\nA total of 40 postmenopausal women are planned to participate, with 20 participants in each group. Participants will undergo an initial medical examination and baseline assessments, including demographic and health information, dietary habits, menopausal symptoms, sleep quality, physical activity, and dietary intake. Anthropometric measurements, body composition, handgrip strength, blood pressure, and biochemical parameters will also be assessed.\n\nParticipants in the intervention group will follow a time-restricted eating schedule in which they will consume food within an 8-hour daily eating window and fast for 16 hours. The eating window will begin between 8:00 AM and 12:00 PM and will be determined by the participant. During the fasting period, water, unsweetened tea, plain coffee, and plain mineral water will be permitted. Participants in the control group will follow a personalized energy-restricted diet providing approximately 25% less energy than their estimated energy requirements. The diet will be planned according to menopausal nutrition recommendations and individual preferences.\n\nDietary intake will be monitored every 2 weeks. Anthropometric measurements, blood pressure, and handgrip strength will be assessed every 4 weeks. All baseline assessments will be repeated after the 12-week intervention period. The study hypothesis is that time-restricted eating will result in greater improvements than the personalized energy-restricted diet in anthropometric measurements and body composition, biochemical parameters, blood pressure, handgrip strength, menopausal symptoms, and sleep quality in obese postmenopausal women.",[163,164,165],"Obesity (BMI Equal to or >30)","Postmenopausal Symptoms","Sleep Quality",[167,168,169,165,170],"Postmenopause","Obesity","Time Restricted Eating","Calorie Restricted Diets","NOT_YET_RECRUITING","2026-10-08",{"date":174,"type":175},"2026-10-14","ACTUAL",{"date":177,"type":157},"2026-11-01",{"date":179,"type":157},"2027-10-31",{"name":5,"class":6},1]